Lumosa Therapeutics Co., Ltd. (TPEX:6535)

Lumosa Therapeutics Revenue

Lumosa Therapeutics had revenue of 4.48M TWD in the quarter ending March 31, 2026, a decrease of -49.61%. This brings the company's revenue in the last twelve months to 31.42M, down -27.92% year-over-year. In the year 2025, Lumosa Therapeutics had annual revenue of 35.83M, down -8.49%.

• Revenue (ttm): 31.42M
• Revenue Growth: -27.92%
• P/S Ratio: 613.05
• Revenue / Employee: 872.72K
• Employees: 39
• Market Cap: 19.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.83M	-3.32M	-8.49%
Dec 31, 2024	39.15M	-17.76M	-31.21%
Dec 31, 2023	56.92M	30.27M	113.63%
Dec 31, 2022	26.64M	9.28M	53.45%
Dec 31, 2021	17.36M	-4.29M	-19.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error